• Skip to main content
Daily Citizen
  • Subscribe
  • Categories
    • Culture
    • Life
    • Religious Freedom
    • Sexuality
  • Parenting Resources
    • LGBT Pride
    • Homosexuality
    • Sexuality/Marriage
    • Transgender
  • About
    • Contributors
    • Contact
  • Donate

marijuana

Sep 23 2026

Idaho Ballot Measure Would Lock Out Companies Looking to Legalize Weed

Idaho voters have spent 15 years squashing proposal after proposal to legalize marijuana. Now, this November, Idaho citizens will choose whether to give their elected representatives sole authority over state drug policy.

The proposed Grant Legislature Exclusive Authority and Prohibit Citizen-Initiated Measures on Marijuana, Narcotics and Psychoactive Substances Amendment (HJR 4) would remove citizens’ authority under the state Constitution to create ballot measures dictating drug policy.

Proponents of HJR 4, which passed the Idaho House and Senate in 58-10 and 29-6 votes, respectively, say it would insulate state from rich weed companies that fund marijuana legalization campaigns.

“The proposed constitutional amendment ensures that out-of-state weed barons are not able to hijack the Idaho ballot initiative process and legalize marijuana,” Blaine Conzatti, president of the Focus on the Family-allied Idaho Family Policy Center, told the Daily Citizen.

“The adoption of HJR 4 would reserve those decisions for the people of Idaho acting through their elected representatives.”

Idahoans are already familiar with marijuana industry pressures. A measure to legalize medical marijuana has been proposed in every Idaho state election since 2012. In 2022, a measure to legalize the recreational use and sale of marijuana was floated.

But, in 15 years, no marijuana legalization campaign has ever gathered enough signatures to get a proposed measure on the ballot — likely because Idaho’s citizens understand marijuana devastates people physically and mentally.

A comprehensive UCLA analysis of marijuana research published between January 2010 and September 2025 found the drug successfully treats only three medical conditions:

  • Appetite loss caused by HIV/AIDS.
  • Nausea and vomiting caused by chemotherapy.
  • Some pediatric seizure disorders.

Beyond these illnesses, researchers concluded evidence “does not support the use of cannabis or cannabinoids for most conditions for which it is promoted, such as acute pain or insomnia.”

In fact, the same study connected daily, high-potency marijuana use to higher rates of heart disease and greater risk of stroke.

Prolonged marijuana use can also lead to cannabinoid hyperemesis syndrome (CHS), a condition causing debilitating nausea and vomiting that can be fatal if left untreated.

Decades of research links marijuana consumption to the development of psychosis and serious mental illness. As the Daily Citizen previously reported:

  • People who smoke high-THC marijuana daily are five times as likely to develop a psychotic disorder than those who don’t smoke (The Lancet; 2019).
  • As many as one in 200 individuals who ingest marijuana experience cannabis-associated psychotic symptoms (Nature; 2024).
  • A cannabis-induced psychotic episode has a 47% chance of triggering schizophrenia or bipolar disorder — a higher likelihood than psychotic episodes induced by alcohol, opioids, sedatives, cocaine and amphetamines (American Journal of Psychiatry; 2017).

Adolescents face an even higher probability of developing serious mental health problems after ingesting marijuana. A recent study of nearly 500,000 teens between 13 and 17 years old found those who ingested marijuana, no matter how much, were more than twice as likely as their peers to develop bipolar or psychotic disorder by the time they turned 26.

States which legalize marijuana also tend to experience unintended ripple effects — like skyrocketing rates of pediatric exposure to marijuana.

A year after Ohio legalized marijuana in 2023, nearly 600 children five years old or younger were admitted to hospitals after ingesting the drug — a more than 1,100% increase from 2018, when hospitals first started keeping track.

The children reportedly experienced symptoms including breathing problems, problems with their central nervous systems, vomiting, hallucinations and seizures.

But HJR 4 protects Idaho citizens from more than just marijuana. The proposed constitutional amendment would also prevent citizens from changing laws around narcotics and psychoactive substances.

“Idaho residents watched as our neighboring state of Oregon decriminalized illicit drugs through a ballot initiative and immediately saw an explosion in violent crimes, property crime and moral decline,” Conzatti told the Daily Citizen.

“Adopting HJR 4 ensures that Idaho will not experience the same fate.”

Oregon Governor Tina Kotek signed House Bill 4002, which recriminalized the possession of meth, fentanyl and other hard drugs, on April 1, 2024.

The law undid changes made by Measure 110, a ballot initiative which made having and using hard drugs punishable by a mere $100 fine. The measure made Portland “a homeless drug addict’s slice of paradise,” one homeless person told The New York Times in July 2023.

The Idaho state Constitution states “the first concern of all good government is the virtue and sobriety of the people, and the purity of the home … [and] for the promotion of temperance and morality.”

But Idaho representatives cannot fulfill this charge if drug companies with deep pockets and other radical interests seek to use citizen-led ballot initiatives to change Idaho’s drug policy.

“The Idaho legislature takes seriously this constitutional charge and has consistently restricted access to harmful psychoactive substances like marijuana,” Conzatti concludes.

“Decriminalizing or further restricting drug use should remain he prerogative of the state legislature.”

If you live in Idaho, please consider voting “Yes” this November 3 on HJR 4, the Grant Legislature Exclusive Authority and Prohibit Citizen-Initiated Measures on Marijuana, Narcotics and Psychoactive Substances Amendment.

Readers in other states, please educate your children about the harmful effects of marijuana and chemically-altered hemp products. Click on the articles below to learn more.

Additional Articles and Resources

Oregon Lawmakers Vote to Recriminalize Hard Drugs

Feds Deregulate Marijuana

Senate Waffles on Banning Hemp-Derived THC

Written by Emily Washburn · Categorized: Culture · Tagged: marijuana

Apr 24 2026

Feds Deregulate Marijuana

The U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) deregulated FDA-approved marijuana products today to “strengthen medical research.”

The decision carries out President Trump’s executive order from December which directed the DOJ to explore reclassifying marijuana from a Schedule I drug, which has no accepted medical use and a high likelihood of abuse, to a Schedule III drug, which has “moderate to low potential for physical and psychological dependence.”

“These actions provide immediate and long-term clarity to researchers, patients and providers alike while still maintaining strict federal controls against illicit drug trafficking,” the DOJ wrote in a press release.

A hearing to “evaluate broader changes to marijuana’s status under federal law” will begin in June, per the release, indicating the Trump administration may be considering loosening federal regulations on marijuana.

Right now, the reclassification only applies to states which have legalized the drug.

The Trump administration claims reclassifying marijuana as a less dangerous drug will facilitate more research of its medical benefits. But Kevin A. Sabet, Ph.D., the president and CEO of Smart Approaches to Marijuana and the Foundation for Drug Policy Solutions, argues it does no such thing.

“Marijuana is already one of the most studied drugs in the world,” Sabet wrote in a scathing piece for Compact just three days before DOJ’s announcement. “Rescheduling it will do little to enable new research; Nor will it unlock potential therapies.”

Instead, Sabet suggested readers follow the money. Rescheduling marijuana would provide significant tax-relief for the marijuana industry, totaling up to $2 billion, by some estimates.

One thing is for sure: The decision to deregulate marijuana reflects industry myths, not scientific fact.

The industry swears marijuana isn’t addictive. But modern marijuana causes addiction, in part, because it contains high average concentrations of THC, the chemical which gets you high.

Modern marijuana products contain an average of 15% to 20% THC, with some containing up to 99%. In 1995, marijuana had an average THC concentration of 4%.

A New York Times analysis of the 2022 U.S. Survey on Drug Use and Health found one-third of adult marijuana users — 18 million people — demonstrated symptoms of cannabis use disorder (CUD), meaning they could not stop using marijuana if they wanted to.

The Times estimated three million of those users were addicted to marijuana.

Decades of research link marijuana consumption to the development of psychosis and serious mental illness. As the Daily Citizen previously reported:

  • People who smoke high-THC marijuana daily are five times as likely to develop a psychotic disorder than those who don’t smoke (The Lancet; 2019).
  • As many as one in 200 individuals who ingest marijuana experience cannabis-associated psychotic symptoms (Nature; 2024).
  • A cannabis-induced psychotic episode has a 47% chance of triggering schizophrenia or bipolar disorder — a higher likelihood than psychotic episodes induced by alcohol, opioids, sedatives, cocaine and amphetamines (American Journal of Psychiatry; 2017).

In his piece for Compact, Sabet cited a new study of nearly 500,000 adolescents between 13 and 17 years old which found subjects who ingested marijuana, no matter how much, were more than twice as likely to develop bipolar or psychotic disorder by the time they turned 26.

Marijuana consumption can also cause physical illness. A comprehensive UCLA analysis of marijuana research published between January 2010 and September 2025 found daily, high-potency marijuana use correlated with higher rates of heart disease and greater risk of stroke.

Prolonged use can also lead to cannabinoid hyperemesis syndrome (CHS), a condition causing debilitating nausea and vomiting that can be left fatal if left untreated.

Marijuana’s effects on adults are bad enough. But when states “legalize” marijuana, pediatric exposures to the drug skyrocket, too.

Sabet used Ohio, which legalized marijuana in 2023, for example.

A year later, in 2024, nearly 600 children five years old or younger were admitted to hospitals after ingesting marijuana — a more than 1,100% increase from 2018, when hospitals first started keeping track.

The children reportedly experienced symptoms including breathing problems, problems with their central nervous systems, vomiting, hallucinations and seizures.

Children ingest marijuana, in part, because the marijuana industry infamously make their products appealing to children — creating vape juices with 91% THC concentration in flavors like watermelon or edibles mimicking the packaging of popular candies.

What groundbreaking medical benefits could justify further deregulating marijuana, when the expanding industry is already causing so much harm, particularly with the proliferation of hemp THC?

The Daily Citizen isn’t sure. According to the UCLA analysis, evidence shows marijuana successfully treats only three medical conditions:

  • Appetite loss caused by HIV/AIDS.
  • Nausea and vomiting caused by chemotherapy.
  • Some pediatric seizure disorders.

Beyond these illnesses, researchers concluded evidence “does not support the use of cannabis or cannabinoids for most conditions for which it is promoted, such as acute pain or insomnia.”

Marijuana consumption harms American citizens, as Focus on the Family President Jim Daly pointed out in December. Deregulation exacerbates these harm and perpetuates industry lies that marijuana products can cure everything from sleepless nights to chronic pain.

If the Trump administration wants to prevent addiction and prioritize recovery, as it articulated in the Great American Recovery Initiative, it should focus on closing regulatory loopholes which allow the marijuana industry to market to children — not making dangerous drugs even more accessible.

Additional Articles and Resources

Counseling Services

Request A Consult

Help With Substance Abuse and Addiction

Talking With Your Teens About Drugs and Alcohol

President Trump Unveils Plan to Combat Drug and Alcohol Addiction

Focus’ Jim Daly to Pres. Trump: Strongly and Unequivocally Oppose Reclassification of Marijuana

President Trump Loosens Restrictions on Marijuana — But the Grass Isn’t Greener on the Other Side

THC-Laced Snacks Marketed to Kids, Hemp to Blame

Marijuana Causing Psychosis in Young People, Legacy Media Late to Party

JD Vance Celebrates Mother’s 10-Year Sobriety at White House: ‘You Made It’

New Law Increases Penalties for Manufacturing, Distributing Fentanyl

Written by Emily Washburn · Categorized: Culture · Tagged: drugs, marijuana

Jan 30 2026

President Trump Unveils Plan to Combat Drug and Alcohol Addiction

President Donald Trump signed an executive order yesterday to establish the Great American Recovery Initiative — an interdisciplinary group of officials which will coordinate the federal push against drug and alcohol addiction

“The Great American Recovery Initiative will bring together federal, state, local and private sector resources to support addiction recovery, treatment and prevention,” President Trump explained in a press conference announcing the order.

“It will help mobilize the full resources and authority of the federal government to help stop this tremendous plague.”

The initiative prioritizes three goals:

  • Preventing addiction
  • Prioritizing treatment
  • Celebrating recovery

The president’s executive order empowers the initiative to ensure federal financial resources, recovery programs and messaging about drugs and alcohol effectively support these three priorities.

The initiative will also connect the federal government with local groups, including faith-based groups, fighting drug and alcohol addiction in their communities.

The Great American Recovery Initiative reflects the Trump administration’s position that drug and alcohol addiction negatively affects all Americans.

“Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability and lost productivity that together cost the United States hundreds of billions of dollars each year,” a fact sheet on the initiative emphasizes.

“Recovery is not a side issue,” Health and Human Services Secretary Robert F. Kennedy Jr. reiterated at the press conference. “It’s an economic issue, a workforce issue, a family issue and a national security issue.”

Secretary Kennedy will co-chair the initiative with Kathryn Burgum, the White House’s new Senior Advisor for Addiction Recovery. Both achieved long-term recovery from addiction.

Kennedy and Burgum are just two of several prominent members of the Trump administration affected by drug and alcohol addiction. Steve Witkoff’s, the president’s special envoy to the Middle East, son tragically died of a drug overdose. White House Chief of Staff Susie Wiles’ father, Pat Summerall, battled addiction on a national stage. Vice President J.D. Vance’s mom, Beverly Aikins, celebrated 10 years of sobriety in April 2025. President Trump’s brother, Fred Trump, died of a heart attack related to alcohol addiction at just 42 years old.

“These stories matter because they are not isolated,” Burgum explained. “They reflect the reality of over 190 million Americans — that’s half our nation who are impacted in some way by the disease of addiction.”

The Daily Citizen supports federal efforts to prevent addiction and heal families and communities from the lingering consequences.

Additional Articles and Resources

Counseling Services

Request A Consult

Help With Substance Abuse and Addiction

Talking With Your Teens About Drugs and Alcohol

JD Vance Celebrates Mother’s 10-Year Sobriety at White House: ‘You Made It’

New Law Increases Penalties for Manufacturing, Distributing Fentanyl

Written by Emily Washburn · Categorized: Culture · Tagged: drugs, marijuana

Dec 19 2025

President Trump Loosens Restrictions on Marijuana — But the Grass Isn’t Greener on the Other Side

President Donald Trump signed an executive order yesterday directing the Department of Justice to start loosening legal restrictions on marijuana.

The order, titled “Increasing Medical Marijuana and Cannabidiol Research,” opens the door for the federal government to reclassify marijuana from Schedule 1, a category of drugs which offer no medical benefit, to Schedule 3, a category of drugs which have “a moderate to low potential for physical and psychological dependence.”

The president’s decision to deregulate marijuana reportedly follows more than a year — and several million dollars-worth — of lobbying by the cannabis industry, which promotes marijuana and CBD products for a plethora of medical conditions.

“The facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” President Trump said in defense of the order.

A recent, comprehensive UCLA analysis of marijuana research published between January 2010 and September 2025 found marijuana and CBD products effectively treat only a few medical conditions — specifically:

  • Appetite loss caused by HIV/AIDS.
  • Nausea and vomiting caused by chemotherapy.
  • Some pediatric seizure disorders.

Beyond these ailments, the analysis concluded, evidence “does not support the use of cannabis or cannabinoids for most conditions for which it is promoted, such as acute pain and insomnia.”

Marijuana and CBD products shouldn’t be a first resort for treating medical conditions like pain, the UCLA report concluded, in part, because they can cause significant health problems.

The analysis links high-potency marijuana — marijuana with a 10% or higher concentration of delta9-THC, the chemical which makes people high — to significantly increased rates of psychosis and anxiety disorders.

Modern marijuana products contain an average THC concentration between 15% and 20%. Some products contain as much as 99% THC.

UCLA’s findings echo conclusions from several other studies, including:

  • People who smoke high-THC marijuana daily are five times as likely to develop a psychotic disorder than those who don’t smoke (The Lancet; 2019).
  • As many as one in 200 individuals who ingest marijuana experience cannabis-associated psychotic symptoms (Nature; 2024).
  • A cannabis-induced psychotic episode has a 47% chance of triggering schizophrenia or bipolar disorder — a higher likelihood than psychotic episodes induced by alcohol, opioids, sedatives, cocaine and amphetamines (American Journal of Psychiatry; 2017).

Excessive marijuana use also causes physical problems.

UCLA’s analysis found daily, high-potency marijuana use correlated with higher rates of heart disease and greater risk of heart attack and stroke. People who use marijuana every day can also develop cannabinoid hyperemesis syndrome (CHS), a condition causing debilitating nausea and vomiting which can be fatal if left untreated.

Though scientific evidence raises serious concerns about the mental and physical consequences of ingesting marijuana, Americans seem largely unaware of the attendant dangers.

The cannabis industry’s lies about marijuana’s “health benefits” make the truth difficult to discern.

“One of the most brilliant PR campaigns for marijuana was to push the word ‘medical’ in front of the word marijuana,” Dr. Kevin Sabet, the founder of Smart Approaches to Marijuana, told the Daily Citizen in 2021.

“It allowed people to have permission to be okay with marijuana because, not only is it not bad for you, but now it’s good for you.”

“I feel like [we were] duped into believing marijuana’s not addictive, [that] it’s just a plant, [that] it will cure your anxiety,” Jordan Davidson, a 22-year-old recovering marijuana addict, told The Wall Street Journal in 2023.

Davidson found himself addicted to the drug after using it to treat his anxiety.

A 2018 survey of people in North America found one in four reported using marijuana or CBD to treat anxiety, chronic pain and problems sleeping — all of which the cannabis industry falsely swears marijuana can treat.

As the United States moves toward further deregulating marijuana, parents must double down on busting these three common marijuana myths.

The cannabis industry claims marijuana is harmless. But more than two decades of evidence shows marijuana is physically and mentally dangerous.

The cannabis industry claims marijuana is natural. But manufacturers chemically modify today’s cannabis products to make them more potent.

The cannabis industry claims marijuana is not addictive. But it is — particularly at high concentrations of THC.

UCLA’s analysis estimates as many as 29% of people who use “medical” marijuana suffer from cannabis use disorder, meaning they cannot voluntarily stop using the drug.

A New York Times analysis of data from the 2022 U.S. Survey on Drug Use and Health determined one in three American adults who reported using marijuana daily or almost daily demonstrated symptoms of cannabis use disorder.

Of the nearly 4.5 million 18- to 25-year-olds who reported using cannabis daily or almost daily, more than four in five displayed signs of cannabis use disorder.

The grass is not greener on the other side of deregulating marijuana — regardless of the cannabis industry’s claims. The Daily Citizen prays Americans won’t have to find out the hard way.

Additional Articles and Resources

Focus’ Jim Daly to Pres. Trump: Strongly and Unequivocally Oppose Reclassification of Marijuana

Talking With Tweens About Marijuana

Talking With Your Teens About Drugs and Alcohol

Parents — Time to Tackle Marijuana Myths

THC-Laced Snacks Marketed to Kids, Hemp to Blame

Marijuana Causing Psychosis in Young People, Legacy Media Late to Party

The Vicious Truth About Drug Addiction and Alcoholism

How the Marijuana Industry is Campaigning to Hook Your Kids on a Drug that Will Damage their Brain

The Surgeon General Announces New Advisory on the Dangers of Marijuana for Pregnant Women and Adolescents

Federal Legalization of Marijuana Gains Steam. Here are the Downsides to Legalization.

Focus on the Family Resources for Mental Health

Written by Emily Washburn · Categorized: Culture · Tagged: marijuana

Dec 15 2025

Focus’ Jim Daly to Pres. Trump: Strongly and Unequivocally Oppose Reclassification of Marijuana

In recent days, President Donald Trump has indicated a willingness to reclassify marijuana from a ‘Schedule I controlled substance’ to a ‘Schedule III’ – a significant and troubling shift in American drug policy.

The Schedule I drug classification communicates the substance’s highly addictive and destructive nature. A new study that analyzed over 15 years of research found that use of marijuana is known to significantly increase episodes of psychosis and anxiety. Long seen as a “gateway drug,” it’s also often the starting point for many users who go on to struggle with a lifetime of broader and more extensive addiction.

Should President Trump downgrade marijuana to Schedule III, the substance would be in the same category as anabolic steroids and Tylenol with codeine.

Earlier this year, Mr. Trump acknowledged the strong opinions about the drug.

“Some people like it, some people hate it,” the president said. “Some people hate the whole concept of marijuana.”

It’s no wonder why.

Use of cannabis increases a person’s chance of developing a bipolar disorder or schizophrenia by an average of 47%. It’s also shown to significantly increase hallucinations and paranoia.

Should the president issue an executive order downgrading the drug, the Justice Department would then move to reschedule as recommended.

What’s the case for the reevaluation and reclassification?

Supporters are pushing for it because they contend it would make it easier to research the drug and presumably find new uses and benefits. Yet the most recent research has found that the hype surrounding the medical claims and benefits of marijuana are wildly overblown.

In fact, it’s been determined that regular use of medical marijuana leads to a higher chance of heart attack, stroke and coronary artery disease.

Not surprisingly, pro-pot companies are pouring money into the political coffers of representatives and urging them to support the reclassification of the drug.

Media reports indicate Speaker of the House Mike Johnson has urged the president to not reclassify the drug. An article in last week’s Washington Post suggested the Speaker shared his concerns via telephone but that he was rebuffed by several administration officials.

As a member of the House, Speaker Johnson’s opposition to both the decriminalization of marijuana and the expansion of pot access has been clear. Citing the distortion and abuse inside the industry, he’s opposed the Medical Marijuana Research Act and the Medical Marijuana and Cannabidiol Research Expansion Act back in 2022.

Focus on the Family president Jim Daly has written to President Trump and urged him to not classify the drug. “Having lived in Colorado, one of the early states to legalize pot, I can attest to its harm,” Daly noted Monday.

In a letter delivered to President Trump last week, Jim Daly urged:

Not only is marijuana addictive, but it also impairs cognitive function and judgment – thus increasing the risk of motor vehicle and other accidents. To add insult to injury, pot is detrimental to users physical health and can increase the likelihood of chronic lung disease and even cancer. 
With all of this in mind, it is imperative for our federal government and leaders to continue sending a strong message about the negative impact of marijuana use and addiction. I pray that you will strongly and unequivocally oppose this reclassification effort for the sake of the health and well-being of American citizens.

President Biden was considering a similar reclassification but ultimately decided against doing so.

Loosening federal restrictions on marijuana is a bad idea that threatens and hurts the health of the very people in purports to help. If the established goal is to make America healthy and great again, this objective will not be reached by increasing access to poisonous pot.

Written by Paul Batura · Categorized: Culture · Tagged: marijuana

  • Page 1
  • Page 2
  • Go to Next Page »

Privacy Policy and Terms of Use | Privacy Policy and Terms of Use | © 2026 Focus on the Family. All rights reserved.

  • Cookie Policy